Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00388349 · ClinicalTrials.gov registry record · Phase 2

Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease

A Phase 2 study of Lymphoma and Hodgkin Disease, sponsored by Stanford University.

Completed
Registry status
Phase 2
Development phase
146
Enrollment target
1
Study location

NCT00388349 is a Phase 2 study of Lymphoma and Hodgkin Disease that has completed, run by Stanford University. The registered enrollment target is 146 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00388349, a Phase 2 study of Lymphoma and Hodgkin Disease, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 2
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

This is a phase 2 study of gemcitabine + high-dose chemotherapy followed by peripheral blood stem cell (PBSC) rescue for Hodgkin's Disease

Conditions Studied

Lymphoma Hodgkin Disease Hodgkin's Lymphoma

Interventions

  • DRUG Cyclophosphamide
  • DRUG Etoposide
  • DRUG Gemcitabine
  • DRUG Carmustine
  • DRUG Vinorelbine

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2001-09
Est. Completion 2010-09
Phase Phase 2

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00388349

The ClinicalTrials.gov registry entry for NCT00388349 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (70% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lymphoma appearing as the primary indexed condition, and to 5 interventions - of which Cyclophosphamide is the first listed.

NCT00388349 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00388349 about?

NCT00388349 is a clinical study titled "Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease". This is a phase 2 study of gemcitabine + high-dose chemotherapy followed by peripheral blood stem cell (PBSC) rescue for Hodgkin's Disease

What is the current status of trial NCT00388349?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 146 participants. The study started on 2001-09. Estimated completion is 2010-09.

What conditions does trial NCT00388349 study?

This clinical trial studies the following conditions: Lymphoma, Hodgkin Disease, Hodgkin's Lymphoma.

What interventions are being tested in trial NCT00388349?

The interventions under investigation include: Cyclophosphamide (DRUG), Etoposide (DRUG), Gemcitabine (DRUG), Carmustine (DRUG), Vinorelbine (DRUG).

Who is sponsoring clinical trial NCT00388349?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00388349 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lymphoma

All registered trials for this condition

Hodgkin Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.